Peer-influenced content. Sources you trust. No registration required. This is HCN.
Science tells us that face masks can prevent coronavirus transmission and save lives; however, all masks are not created equal. The WHO and CDC both recommend fabric face masks for the general public, but what about neck scarves and other types? Here’s how scientists have ranked mask materials so far, from the most to least protective.
Allergy & Immunology August 18th 2020
In this research article, the authors demonstrate a simple optical measurement method to evaluate the efficacy of masks to reduce the transmission of respiratory droplets during regular speech. They tested 14 commonly available masks or masks alternatives, one patch of mask material, and a professionally fit-tested N95 mask.
Allergy & Immunology August 17th 2020
Healthgrades for Professionals
According to the 2019 State Physician Workforce Data Report published by the Association of American Medical Colleges, for every 100,000 people living in the US, there are 277.8 physicians. Check out this list from Healthgrades, which outlines the top 5 states with the highest number of physicians, as well as the top 5 lowest.
Whether you’re a resident looking for your first job or itching for a change of scenery, there are plenty of websites out there that can assist in the hunt. But where do you start? Thankfully, Healthgrades features five outstanding job listing platforms for physicians looking to make a move or beginning their career in medicine.
Allergy & Immunology August 10th 2020
As the COVID-19 pandemic uses up health resources, there are a few older diseases that are re-emerging, most notably tuberculosis, HIV, and malaria. Although the cases of these diseases were at their lowest point in 2018, some physicians are fearing that the COVID-19 risks are taking these diseases back to where we were 20 years ago.
Annals of Internal Medicine
No effective oral therapy exists for the outpatient treatment of COVID-19. Hydroxychloroquine has in vitro activity against SARS-CoV-2 and has been proposed as a potentially effective treatment. This randomized double-blind, placebo-controlled trial investigated whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients.
Family Medicine/General Practice August 5th 2020